Proud to Be a Major Part of Canadian Healthcare
Teva is the largest manufacturer of generic drugs in the world, and we are among the world's top 10 pharmaceutical companies.
Here in Canada, Teva makes both generic and brand-name pharmaceuticals. With nearly 200,000* prescriptions filled each day, we understand the shared role of brand-name and generic medications in a sustainable healthcare system.
We offer more than 400 brand and generic medications, to treat everything from ear infections to diabetes, heart disease and cancer. Our proven generic products are easily recognizable through prefixes such as “Novo-,” “ratio-” and “Teva-.”
Because our generic products are priced substantially lower than their brand equivalents, we save Canada’s healthcare system more than $3 billion annually.
Teva’s brand-name division, Teva Canada Innovation, is a leader in developing specialty medicines that meet patient needs, most significantly in central nervous system and pain. In Canada, Teva's innovative portfolio includes six leading proprietary drugs:
• Copaxone® (glatiramer acetate injection)
• Azilect® (rasagiline tablets)
• Frova® (frovatriptan succinate tablets)
• Divigel® (estradiol gel)
• Fentora® (fentanyl buccal tablets)
• Alertec® (modafanil tablets).
We’re proud to be a major part of Canadian healthcare. We invite you to find out more about us: Explore our long history in Canada, view our facilities and learn about our industry. Here, you will also find the promise of an enriching career in our employment opportunities.
*IMS CompuScript MAT April 2015